BioVentrix is based in Mansfield. It has raised $189M in total funding. Latest round: Series E.
BioVentrix funding overview
BioVentrix is based in Mansfield. BioVentrix has raised $189M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in April 2026. The round record for BioVentrix runs through 2026; nothing later has been disclosed. Investors on record include Telegraph Hill Partners, Andera Partners, Cormorant Asset Management, Taglich Brothers Inc., Squarepoint Capital, Richmond Brothers. 6 distinct backers are named across the disclosed rounds.
BioVentrix has raised $189M in total disclosed funding across the rounds on record.
Who has invested in BioVentrix?
Telegraph Hill Partners, Andera Partners, Cormorant Asset Management, Taglich Brothers Inc., Squarepoint Capital, Richmond Brothers are named among the investors backing BioVentrix.
What was the latest BioVentrix funding round?
The most recent disclosed round is a Series E, announced in April 2026.
Where is BioVentrix based?
BioVentrix is based in Mansfield.
When did BioVentrix last raise?
The last disclosed BioVentrix round closed in April 2026 at Series E.
We update the BioVentrix record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Mansfield and their backers are listed below.
